<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Biomedical</title>
	<atom:link href="http://pharmaexecnews.com/category/biotechnology/biomedical/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Breast Implants Can Lead to Cancer</title>
		<link>http://pharmaexecnews.com/biotechnology/breast-implants-lead-cancer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/breast-implants-lead-cancer/#comments</comments>
		<pubDate>Fri, 29 Apr 2011 08:00:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Oncology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11535</guid>
		<description><![CDATA[New research by a team from the RAND Corporation has indicated that a rare type of lymphoma is linked with breast implants. However, the team has said that there is still no evidence to prove that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop.

The study [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/breast-implants-lead-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brain Cell Protein Identified as Potential Target for Obesity and Type 2 Diabetes</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/brain-cell-protein-identified-potential-target-obesity-type-2-diabetes/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/brain-cell-protein-identified-potential-target-obesity-type-2-diabetes/#comments</comments>
		<pubDate>Thu, 28 Apr 2011 14:00:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11531</guid>
		<description><![CDATA[Research from the Einstein College of Medicine at the Yeshiva  University has indicated that there are potential clinical applications of a hypothalamic cell protein for the treatment of obesity and type 2 diabetes. Studies in mouse models by the research team has shown that over expression of thioredoxin-interacting protein (TXNIP) by hypothalamic nutrient-sensing cells [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/brain-cell-protein-identified-potential-target-obesity-type-2-diabetes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Identify Gene Required for Repairing Damaged Muscle</title>
		<link>http://pharmaexecnews.com/biotechnology/scientists-identify-gene-required-repairing-damaged-muscle/</link>
		<comments>http://pharmaexecnews.com/biotechnology/scientists-identify-gene-required-repairing-damaged-muscle/#comments</comments>
		<pubDate>Thu, 28 Apr 2011 08:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11526</guid>
		<description><![CDATA[Researchers at the UMDNJ-Robert Wood Johnson  Medical School have come a step closer to treating, and maybe even preventing, muscle damage which is caused by neurodegenerative disorders and other forms of disease. In a newly published study, the researching team has disclosed that they have found that the gene polymerase I and transcript release [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/scientists-identify-gene-required-repairing-damaged-muscle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 14:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11514</guid>
		<description><![CDATA[New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.

According to George C. Ebers, MD, with the University of Oxford in the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Targeted Photodynamic Therapy for Treating Skin Cancer</title>
		<link>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/#comments</comments>
		<pubDate>Fri, 22 Apr 2011 14:00:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11481</guid>
		<description><![CDATA[Research by Swiss and British scientists has shown that targeted photodynamic therapy has the potential to completely eradicate some models of cancer.  The team – consisting of researchers from the University of Hull and ETH Zurich – combined light-sensitive molecules with antibodies that specifically target tumor blood vessels. When irradiated with light, the molecules produce [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Generation of Medicines with Evolution of Biomolecules</title>
		<link>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/</link>
		<comments>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/#comments</comments>
		<pubDate>Wed, 20 Apr 2011 08:00:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11477</guid>
		<description><![CDATA[A research team from the Harvard University has harnessed the ability of fast-replicating bacterial viruses, also known as phages, to accelerate the evolution of biomolecules in the laboratory. This latest research has the potential to ultimately allow the tailoring of custom pharmaceuticals and research tools from lab-grown proteins, nucleic acids, and other such compounds.

The researchers, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Production of Mercury by Microorganisms to be Researched</title>
		<link>http://pharmaexecnews.com/biotechnology/production-mercury-microorganisms-researched/</link>
		<comments>http://pharmaexecnews.com/biotechnology/production-mercury-microorganisms-researched/#comments</comments>
		<pubDate>Tue, 19 Apr 2011 08:00:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11469</guid>
		<description><![CDATA[A new research study on the sequenced bacterial genome conducted by a team from the Department of Energy&#8217;s Oak Ridge National Laboratory has the possibility of revealing clues as to how microorganisms produce a highly toxic form of mercury.

Methylmercury, a potent human neurotoxin, appears in the environment when some specific naturally occurring bacteria transform inorganic [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/production-mercury-microorganisms-researched/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India Agrees to Check for Superbug</title>
		<link>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/</link>
		<comments>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 14:00:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11465</guid>
		<description><![CDATA[After many days of openly denying the &#8220;existence and public health importance&#8221; of the NDM-1 gene, India has finally agreed to search for the presence of superbugs in the Capital and its water supply lines.Quietly yielding under pressure, the National Centre for Disease Control (NCDC) has agreed to lead a study to detect the &#8220;prevalence [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insulin Might be Potential Cure for Alzheimer&#8217;s</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/insulin-potential-cure-alzheimers/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/insulin-potential-cure-alzheimers/#comments</comments>
		<pubDate>Thu, 14 Apr 2011 14:00:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11446</guid>
		<description><![CDATA[In research conducted by the University at Buffalo, it has been proven that a low dosage of insulin has the ability to restrict the expression in the blood of four precursor proteins involved in the pathogenesis of Alzheimer&#8217;s disease. Research done by endocrinologists  at the University at Buffalo indicates that insulin might have a powerful [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/insulin-potential-cure-alzheimers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetadi Biotech: Possible to Identify 150 Genetic Syndromes</title>
		<link>http://pharmaexecnews.com/biotechnology/genetadi-biotech-identify-150-genetic-syndromes/</link>
		<comments>http://pharmaexecnews.com/biotechnology/genetadi-biotech-identify-150-genetic-syndromes/#comments</comments>
		<pubDate>Tue, 12 Apr 2011 14:00:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11433</guid>
		<description><![CDATA[In a recent announcement by Genetadi Biotech, the company has announced that a prenatal diagnostic device developed by the company based on amniocentesis is now available. The device is based on microarray technology (genomic hybridization genetic chips) and has a diagnostic resolution that is 100 times more than the common cytogenetic technology available today.

This novel [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/genetadi-biotech-identify-150-genetic-syndromes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

